ARC THERAPIES株式会社
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
ARC Therapies Advances Gut Microbiome Research with YB328 Toward Clinical Application 2025-08-20 07:00
Initiation of cell therapy research and development program for adult T-Cell leukemia / lymphoma (ATLL) 2024-07-11 14:24
Initiation of cell therapy research and development program for adult T-Cell leukemia / lymphoma (ATLL) 2024-07-11 14:21
1